In dairy cows overfed energy before calving, liver tissue sampled about 10 days prepartum already shows broad transcriptomic and metabolomic remodeling in animals that go on to develop clinical ketosis within a week after calving: induced ketone-body synthesis, bile-acid metabolism and amino-acid catabolism pathways, downregulated carbohydrate-metabolism pathways, and inhibited cellular signaling and local immune responses. Whether this remodeling actively predisposes the cow to ketosis, or is a compensatory or coincident response to an underlying state that itself promotes disease, was left explicitly open by the source study and remains unresolved. The problem is to determine this causal direction in vivo, to measure whether the mRNA and metabolite signatures correspond to actual functional impairment (enzyme activities and metabolic flux through the implicated pathways), and to establish how the altered gluconeogenesis, cholesterol and bile-acid handling, amino-acid catabolism, and immune/signaling changes interact mechanistically to produce the clinical phenotype. Whether the signatures and their causal interpretation also hold across other prepartal nutritional regimens, sampling times, and diagnostic thresholds is a natural external-validity extension of this question rather than a required part of it.

Background

High-yielding dairy cows pass through a 'transition period' of roughly three weeks before to three weeks after calving, during which fetal growth, parturition, and the onset of lactation impose energy demands that exceed feed intake. The resulting negative energy balance (NEB) drives mobilization of body fat, releasing non-esterified fatty acids (NEFA) into the blood. The bovine liver takes up large amounts of these fatty acids but, compared with monogastric species, exports triglyceride in very-low-density lipoproteins inefficiently, so periparturient cows are prone to hepatic fat accumulation; the liver must also supply nearly all blood glucose by gluconeogenesis (new synthesis of glucose from precursors such as rumen-derived propionate and amino acids) to sustain lactose synthesis in the mammary gland. When acetyl-CoA produced by fatty-acid oxidation cannot enter the tricarboxylic-acid cycle quickly enough, it is diverted to ketone bodies (acetoacetate, acetone, and beta-hydroxybutyrate, BHB). Clinical ketosis — ketone elevation high enough to cause off-feed, lethargy, and milk drop, typically in the first two weeks of lactation — is among the most prevalent metabolic diseases of dairy cows; its asymptomatic form, subclinical ketosis, is conventionally defined by plasma BHB above roughly 1.2 mmol/L. Because ketosis is diagnosed only after calving, a long-standing question is whether the cow's liver is already 'primed' before parturition. Shahzad, Lopreiato, Liang, Trevisi, Osorio, Xu, and Loor (Journal of Animal Science and Biotechnology 10:96, 2019) addressed this directly: within a cohort of multiparous Holstein cows overfed energy during the last three weeks before calving (close-up diet 1.54 Mcal/kg dry matter), they compared liver biopsy tissue collected at day -10 (plus or minus 3 days) relative to calving from six cows that developed clinical ketosis within 7 days postpartum (urine acetoacetate above 80 mg/dL, requiring veterinary treatment) and six that remained healthy. Using a bovine whole-transcriptome microarray (transcriptomics, i.e. genome-wide measurement of mRNA abundance) and untargeted gas- and liquid-chromatography mass spectrometry metabolomics (measurement of small-molecule metabolites), they found the prepartal transcriptome more extensively altered than the metabolome. Cows destined for ketosis already showed induction of the ketone-body synthesis pathway, primary bile-acid synthesis and transport (with higher hepatic glycochenodeoxycholate), and several amino-acid degradation pathways, alongside downregulation of carbohydrate-metabolism pathways (for example pentose phosphate and inositol phosphate metabolism) and marked inhibition of cell-signaling pathways — among them mTOR signaling (mechanistic target of rapamycin, the central nutrient- and growth-sensing kinase cascade), insulin signaling, and Jak-STAT — as well as immune-related responses, even though systemic inflammatory markers in plasma did not differ between groups. The pathway assignments were inferred bioinformatically from mRNA abundance and metabolite pools (differentially expressed genes mapped onto KEGG pathway databases), not from enzyme activity measurements or metabolic flux (the actual rate of metabolite flow through a pathway). The design was observational, small, and single-regimen. The authors' conclusions state verbatim that 'the causative link between these tissue-level adaptations and onset of clinical ketosis needs to be studied further', and the discussion adds that 'it is unclear if activity and/or flux through the pathways also are compromised in cows that become susceptible to ketosis', calling for studies measuring 'activities of some of the key enzymes in these pathways'. The unresolved question is therefore not whether prepartal hepatic differences exist — that is established — but what they mean causally and functionally.

Problem Statement

Determine whether — and how — the prepartal hepatic remodeling observed in dairy cows that go on to develop clinical ketosis is causally linked to the disease, as left open by Shahzad et al. (2019). Three jointly linked components of this objective — a mechanistic causal account of susceptibility to clinical ketosis anchored in prepartal hepatic function — are: (i) establish the causal direction in vivo — do the prepartal hepatic adaptations (induced ketone-body synthesis; altered gluconeogenesis-related carbohydrate metabolism; altered cholesterol and primary bile-acid handling; induced amino-acid catabolism; inhibited cellular signaling such as mTOR and insulin pathways and localized immune responses) actively predispose the cow to clinical ketosis, or are they compensatory or merely coincident responses to an underlying physiological state (for example negative energy balance, body-condition excess, or low-grade inflammation) that itself promotes disease? (ii) measure whether the transcript and metabolite signatures correspond to functional impairment, that is, enzyme activities and/or metabolic flux through the implicated pathways in prepartal liver of cows that do versus do not develop ketosis; and (iii) establish how these pathway alterations interact mechanistically to produce (or protect against) the clinical phenotype, integrating rather than merely listing the gluconeogenic, bile-acid, amino-acid, and immune/signaling changes. Because the source study used a single nutritional regimen, a single biopsy time, and one diagnostic criterion — noting that factors such as parity, time of sample harvest, and body condition could influence results — whether the identified signatures and their causal interpretation also hold across other prepartal nutritional regimens, sampling times, and diagnostic thresholds is a natural external-validity extension of, but not a required component of, this problem. Correlational co-variation of the signature with disease, by itself, cannot distinguish the predisposing from the compensatory interpretation.

References

  1. Khuram Shahzad, Vincenzo Lopreiato, Yusheng Liang, Erminio Trevisi, Johan S. Osorio, Chuang Xu, Juan J. Loor (2019). Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management. Journal of Animal Science and Biotechnology 10:96. DOI 10.1186/s40104-019-0404-z. https://doi.org/10.1186/s40104-019-0404-z
  2. J. Eduardo Rico, Mario A. Barrientos-Blanco (2024). Invited review: Ketone biology—The shifting paradigm of ketones and ketosis in the dairy cow. Journal of Dairy Science 107(6):3367-3388. DOI 10.3168/jds.2023-23904. https://doi.org/10.3168/jds.2023-23904
  3. Pedro Melendez, Manuel Vizcaino Serrano (2024). Update on ketosis in dairy cattle with major emphasis on subclinical ketosis and abdominal adiposity. Veterinary Medicine and Science 10(5):e1525. DOI 10.1002/vms3.1525. https://doi.org/10.1002/vms3.1525
  4. Haitao Hu, Lamei Wang, Rui Zhang, Mei Tian, Shuo Zhang, Hongrui Li, Chuanjiang Cai, Junhu Yao, Jianguo Wang, Yangchun Cao (2025). An overview of the development of perinatal stress-induced fatty liver and therapeutic options in dairy cows. Stress Biology 5(1):14. DOI 10.1007/s44154-024-00206-5. https://doi.org/10.1007/s44154-024-00206-5
  5. Ryan S. Pralle, Wenli Li, Brianna N. Murphy, Henry T. Holdorf, Heather M. White (2021). Novel Facets of the Liver Transcriptome Are Associated with the Susceptibility and Resistance to Lipid-Related Metabolic Disorders in Periparturient Holstein Cows. Animals 11(9):2558. DOI 10.3390/ani11092558. https://doi.org/10.3390/ani11092558
  6. Ryan S. Pralle, Sophia J. Erb, Henry T. Holdorf, Heather M. White (2021). Greater liver PNPLA3 protein abundance in vivo and in vitro supports lower triglyceride accumulation in dairy cows. Scientific Reports 11:2839. DOI 10.1038/s41598-021-82233-0. https://doi.org/10.1038/s41598-021-82233-0
  7. M. Schären, B. Riefke, M. Slopianka, M. Keck, S. Gruendemann, J. Wichard, N. Brunner, S. Klein, T. Snedec, K. B. Theinert, F. Pietsch, F. Rachidi, G. Köller, E. Bannert, J. Spilke, A. Starke (2021). Aspects of transition cow metabolomics—Part III: Alterations in the metabolome of liver and blood throughout the transition period in cows with different liver metabotypes. Journal of Dairy Science 104(8):9245-9262. DOI 10.3168/jds.2020-19056. https://doi.org/10.3168/jds.2020-19056
  8. O. Bogado Pascottini, J. De Koster, F. Van Nieuwerburgh, M. Van Poucke, L. Peelman, V. Fievez, J. L. M. R. Leroy, G. Opsomer (2021). Effect of overconditioning on the hepatic global gene expression pattern of dairy cows at the end of pregnancy. Journal of Dairy Science 104(7):8152-8163. DOI 10.3168/jds.2020-19302. https://doi.org/10.3168/jds.2020-19302
  9. Zhou-Lin Wu, Shi-Yi Chen, Shenqiang Hu, Xianbo Jia, Jie Wang, Song-Jia Lai (2020). Metabolomic and Proteomic Profiles Associated With Ketosis in Dairy Cows. Frontiers in Genetics 11:551587. DOI 10.3389/fgene.2020.551587. https://doi.org/10.3389/fgene.2020.551587
  10. Ping Sha, Ma Xuehu, Hu Chunli, Feng Xue, An Yanhao, Ma Yun, Ma Yanfen (2024). Multiomics reveals blood differential metabolites and differential genes in the early onset of ketosis in dairy cows. Genomics 116(5):110927. DOI 10.1016/j.ygeno.2024.110927. https://doi.org/10.1016/j.ygeno.2024.110927
  11. Zhiyuan Fang, Xinwei Li, Shu Wang, Qianming Jiang, Juan J. Loor, Xiuhuan Jiang, Lingxue Ju, Hao Yu, Taiyu Shen, Men Chen, Yuxiang Song, Zhe Wang, Xiliang Du, Guowen Liu (2022). Overactivation of hepatic mechanistic target of rapamycin kinase complex 1 (mTORC1) is associated with low transcriptional activity of transcription factor EB and lysosomal dysfunction in dairy cows with clinical ketosis. Journal of Dairy Science 105(5):4520-4533. DOI 10.3168/jds.2021-20892. https://doi.org/10.3168/jds.2021-20892
  12. Bichen Zhao, Ming Li, Huijing Zhang, Jingyi Wang, Wanli Zhao, Yue Yang, Muhammad Usman, Juan J. Loor, Chuang Xu (2025). M1 polarization of hepatic macrophages in cows with subclinical ketosis is an important cause of liver injury. Journal of Dairy Science 108(3):2933-2946. DOI 10.3168/jds.2024-25500. https://doi.org/10.3168/jds.2024-25500
  13. Menglin Liu, Jingmin Gu, Chenchen Zhao, Jinxia Li, Fanrong Kong, Xinyu Du, Dandan Qi, Enzhu Li, Jie Gao, Xiliang Du, Yuxiang Song, Guowen Liu, Wenwen Gao, Xinwei Li, Lin Lei (2025). Hepatocyte necroptosis is associated with liver damage in dairy cows with ketosis. Journal of Dairy Science 108(8):8844-8858. DOI 10.3168/jds.2025-26349. https://doi.org/10.3168/jds.2025-26349
  14. Jun-Jie Xu, Fan Yang, Zhi-Xi Chen, Zhi-Peng Wang, Zi-Xuan Wang, Zi-Han Deng, Chen-Jie Xu, Fang-Hui Chen, Wei Zhang, Yang Liu, Ya-Fei Cai (2025). FGF21–MAPK1 Imbalance Disrupts Hepatic Lipid Metabolism in Dairy Cow Ketosis. Life 15(9):1339. DOI 10.3390/life15091339. https://doi.org/10.3390/life15091339
  15. Zhengzhong Luo, Zhenlong Du, Yixin Huang, Tao Zhou, Dan Wu, Xueping Yao, Liuhong Shen, Shumin Yu, Kang Yong, Baoning Wang, Suizhong Cao (2024). Alterations in the gut microbiota and its metabolites contribute to metabolic maladaptation in dairy cows during the development of hyperketonemia. mSystems 9(4):e00023-24. DOI 10.1128/msystems.00023-24. https://doi.org/10.1128/msystems.00023-24
  16. Huiying Zhao, Liuxue Li, Jian Tan, Ying Wang, Ao Zhang, Yuchao Zhao, Linshu Jiang (2024). Multi-Omics Reveals Disrupted Immunometabolic Homeostasis and Oxidative Stress in Adipose Tissue of Dairy Cows with Subclinical Ketosis: A Sphingolipid-Centric Perspective. Antioxidants 13(5):614. DOI 10.3390/antiox13050614. https://doi.org/10.3390/antiox13050614
  17. Yuchao Zhao, Huiying Zhao, Liuxue Li, Shiqing Yu, Ming Liu, Linshu Jiang (2024). Ceramide on the road to insulin resistance and immunometabolic disorders in transition dairy cows: driver or passenger? Frontiers in Immunology 14:1321597. DOI 10.3389/fimmu.2023.1321597. https://doi.org/10.3389/fimmu.2023.1321597
  18. Nick Hockings, Michael Iwersen, Andrew Hancock, Maciej Oczak (2023). Causal structure search and modeling of precision dairy farm data for automated prediction of ketosis risk, and the effect of potential interventions. Frontiers in Animal Science 4:1180610. DOI 10.3389/fanim.2023.1180610. https://doi.org/10.3389/fanim.2023.1180610
  19. Miguel Chirivi, Daniela Cortes, C. Javier Rendon, G. Andres Contreras (2024). Lipolysis inhibition as a treatment of clinical ketosis in dairy cows: Effects on adipose tissue metabolic and immune responses. Journal of Dairy Science 107(7):5104-5121. DOI 10.3168/jds.2023-23998. https://doi.org/10.3168/jds.2023-23998
  20. Fanlin Kong, Shuo Wang, Yijia Zhang, Chen Li, Dongwen Dai, Cheng Guo, Yajing Wang, Zhijun Cao, Hongjian Yang, Yanliang Bi, Wei Wang, Shengli Li (2025). Rumen microbiome associates with postpartum ketosis development in dairy cows: a prospective nested case-control study. Microbiome 13(1):69. DOI 10.1186/s40168-025-02072-3. https://doi.org/10.1186/s40168-025-02072-3
  21. O. V. Sokolova, M. V. Bytov, A. I. Belousov, N. A. Bezborodova, V. D. Zubareva, N. A. Martynov, O. S. Zaitseva, I. A. Shkuratova (2023). Genetic Susceptibility to Ketosis in Cattle: Current State of Research. Russian Journal of Genetics 59(3):251-262. DOI 10.1134/S1022795423030110. https://doi.org/10.1134/S1022795423030110
  22. A. F. S. Lima, M. H. De Oliveira, G. G. Begalli, R. C. B. Grazziotin, J. Halfen, E. Trevisi, J. S. Osorio (2025). Prepartal liver glutathione and its association with lactation performance, metabolism, and health outcomes in transition dairy cows. Journal of Dairy Science 108(12):13938-13957. DOI 10.3168/jds.2025-26916. https://doi.org/10.3168/jds.2025-26916
  23. Wei Xu, Sandra Grindler, Ákos Kenéz, Sven Dänicke, Jana Frahm, Korinna Huber (2022). Changes of the liver metabolome following an intravenous lipopolysaccharide injection in Holstein cows supplemented with dietary carnitine. Journal of Animal Science and Biotechnology 13:94. DOI 10.1186/s40104-022-00741-z. https://doi.org/10.1186/s40104-022-00741-z
  24. Celien Kemel, Angelique C. M. Rijpert-Duvivier, Nina Strus, Florian Guigui, Frédéric Vangroenweghe (2026). The Future Toolbox for Managing Ketosis in Dairy Cow Herds: A European Key Opinion Leader Consensus. Veterinary Sciences 13(4):344. DOI 10.3390/vetsci13040344. https://doi.org/10.3390/vetsci13040344